Clinical Trial Update: Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of photodynamic therapy with HPPH for recurrent dysplasia, carcinoma in situ, or stage I oral cavity cancer; the study sponsored by Roswell Park C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma in Situ of the Oral Cavity
• Head and Neck Cancer
• Oral Cavity Cancer
• Oral Epithelial Dysplasia

Drugs mentioned

• HPPH (HPPH)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Head and Neck Cancer | Phase 1 | Status: TERMINATED